Last reviewed · How we verify
NCT04827823
Retrospective Evaluation of Posterior Direct Restorations
trial testing Retrospective evaluation of amalgam and composite restorations in Dental Caries Class II in 80 participants. Completed in 15 December 2017.
22 September 2017
Quick facts
| Lead sponsor | Western University, Canada |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 10 May 2017 |
| Primary completion | 22 September 2017 |
| Estimated completion | 15 December 2017 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Retrospective evaluation of amalgam and composite restorations
Conditions studied
- Dental Caries Class II — all drugs for Dental Caries Class II →
Sponsor
Western University, Canada
Who can join
Adults 25 to 85, any sex, with Dental Caries Class II. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This retrospective study aims to evaluate the clinical performance of posterior multi-surface Class II amalgam (AM) and resin composite (RC) restorations placed by dental students over a five-year period.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04827823
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dental Caries Class II
Currently open trials in the same condition.
- NCT06563128 — Clinical Success of Single-Color Universal Resin Composites · NA · active not recruiting
- NCT06265116 — One-Step Universal Adhesives: A 3-year Clinical Trial in Class II Composite Restorations · NA · active not recruiting
- NCT06833528 — Clinical Performance of Novel Alkasite Restorative Material "Cention Forte" in Class II Restorations · NA · active not recruiting
Other Western University, Canada trials
Trials by the same sponsor.
- NCT07485062 — Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 Diabetes · Phase 4 · not yet recruiting
- NCT07372755 — Feasibility and Usability of a Mobile App for Monitoring and Managing Functional Movement Disorders · not yet recruiting
- NCT07302308 — Action Outcome Latencies as a Measure of Sense of Agency in Functional Movement Disorders. · not yet recruiting
- NCT04323423 — The DURATION Study: reDUcing sedentaRy behAviour to Maintain cogniTIve functiON. · NA · withdrawn
- NCT07204301 — Enhancing Patient Comfort and Reducing Anxiety During Flexible Cystoscopy and Bladder Instillation in Bladder Cancer Pat · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04827823 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Western University, Canada
- Last refreshed: 28 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04827823.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing